NanoGroup
Oncological drug PolEpi and perfusion fluid that allows for longer storage of organs intended for transplantation
NanoGroup has raised €637k across 1 funding round, most recently a round in Oct 2022. Based in Warsaw, Poland; active in Healthtech. Data as of 28 Oct 2026.
Warsaw, Polanden.nanogroup.eu ↗
Total raised
€637k
€637,146
Funding rounds
1
Investors
0
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearNanoGroup — funding by year — interactive chart.
Data table
| NanoGroup — funding by year | |
|---|---|
| 2022 | €637k |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-31 | Other | €637k | — | View deal → |
Related news
- NanoGroup pozyskała ponad 3 miliony zł na kontynuację prac badawczo-rozwojowychmamstartup.pl · 2022-11
Similar companies
same sector or country- InPost€2.8BPoland · Transportation
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Allegro€2.0BPoland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData